Loading chart data, please wait.

QuarterCharts

Free financial-data visualization for US-listed equities. Sankey diagrams, multi-statement charts, and SEC-sourced fundamentals for every public ticker.

Indexed: 10,000+ US-listed equities on NYSE + NASDAQ + NYSEAMERICAN + NYSEARCA, including ETFs, ADRs, REITs, MLPs, and BDCs. (as of 2026-08-28) See full breakdown.

Not investment advice. QuarterCharts is not a registered investment adviser. Nothing on this site is intended as personalized investment advice. Always consult a licensed financial professional before making investment decisions.

Product

Charts
Sankey
Profile
Earnings Calendar
Global Hub
API
AI Agents (MCP)
Dashboard

Trust & Legal

About
Coverage
Privacy Policy
Privacy Notice
Privacy Rights Request
Terms of Service
Status
Trademarks
Do Not Sell or Share My Personal Information
Accessibility
Open-source attributions
Contact

Company logos shown on QuarterCharts are trademarks of their respective owners and are used solely for identification of the company whose data is displayed. Their use does not imply endorsement, sponsorship, or affiliation with the trademark owners. Full trademarks policy.

Data sourced from SEC EDGAR and Finnhub. QuarterCharts is not affiliated with SEC or any issuer.

BIO Profile — $651M revenue, -0.1% YoY (Q2 FY2026) | QuarterCharts United States

All markets
United States
Company Profile

USD

BIOCIK 12208SEC EDGAR

Charts Sankey Profile Earnings Watchlist

Overview Price Financials Analysis

BIO

BIOSEC EDGAR

CIK 0000012208 · Quarterly mode · latest period FY2026 (Q2) (ending 2026-06-30) · sourced from SEC EDGAR

View 10-Q on SEC EDGAR

At a glance · FY2026 (Q2)

BIO SankeyFollow the revenue flow through every line of the income statement.Open Sankey

Data & sources

Primary source: SEC EDGAR
Latest reported period: FY2026 (Q2) · 2026-06-30
Filing cadence: Quarterly filings

Revenue

$651M

-$600K -0.1%vs FY2025 (Q2)

Operating Income

$72.6M

-$4.5M -5.8%vs FY2025 (Q2)

Net Income

$371.4M

+$53.6M +16.9%vs FY2025 (Q2)

Gross Profit

$345.8M

+$500K +0.1%vs FY2025 (Q2)

Financial summary · last 4 periods

Metric	2025-09-30	2025-12-31	2026-03-31	2026-06-30
Revenue	$653M	$693.2M	$592.1M	$651M
Gross Profit	$343.4M	$345.2M	$309.4M	$345.8M
Operating Income	$65.3M	-$118.9M	$34.1M	$72.6M
Net Income	-$341.9M	$720M	-$527.1M	$371.4M

View full financials

⌘K

QuarterProfile

⌘K